Skip to main content
. 2018 Oct 20;14(13):1883–1891. doi: 10.7150/ijbs.27854

Figure 1.

Figure 1

PKM2 was upregulated in tumors of cisplatin resistant BC patients. (A) The total enzymatic activity of PKM2 in tumor tissue specimens from normal (n=7) and cisplatin resistant BC patients (n=7). (B) The protein expression of PKM2 in tumor tissue specimens from normal and cisplatin resistant BC patients. (C) The mRNA expression of PKM2 in tumor tissue specimens from normal and cisplatin resistant BC patients. (D) The relative PKM2 activity in tumor tissue specimens from normal and cisplatin resistant BC patients, which is normalized to its proteins expression level as in (B). **, p<0.01; ***, p<0.001.